BRIEF-Thrombogenics' drug Jetrea gains first Latin American approval in Uruguay
July 1 (Reuters) - Thrombogenics Nv
* Thrombogenics' Jetrea gains first latin american approval in uruguay
* Has been approved in Uruguay for treatment of adults with vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns
* Thrombogenics' partner Alcon, which is commercializing Jetrea(r) outside US, will be responsible for launch of drug in Uruguay Source text for Eikon: (bit.ly/1iRjIuz) Further company coverage:
© Thomson Reuters 2017 All rights reserved.